Results 241 to 250 of about 572,911 (283)
Some of the next articles are maybe not open access.
A severe combined immunodeficiency mutation in the mouse
Nature, 1983The most debilitating human lymphoid deficiency disease, known as severe combined immunodeficiency (SCID), impairs the differentiation of both T and B lymphocytes. Affected infants are highly susceptible to recurring infections of viruses, fungi and bacteria and invariably die within 2 yr of birth.
Bosma, G C, Custer, R P, Bosma, M J
openaire +3 more sources
Advances in the treatment of severe combined immunodeficiency
Clinical Immunology, 2022Severe Combined Immunodeficiency (SCID) is the most profound inborn error of immunity affecting cellular and humoral immunity. Hematopoietic stem cell transplantation has been a curative treatment since 1968. Huge progress has been made since then in understanding the underlying genetics, improving outcomes from transplant, and introducing gene therapy
Mary A, Slatter, Andrew R, Gennery
openaire +2 more sources
Chemotactic defects in severe combined immunodeficiency
The Journal of Pediatrics, 1978Cellular and humoral components of leukotaxis were studied serially in four male infants with severe combined immunodeficiency disease. Two of the four, both lacking B and T cells initially, had a significant defect in neutrophil and monocyte chemotaxis.
Savita Pahwa+11 more
openaire +3 more sources
Severe combined immunodeficiencies and related disorders
Nature Reviews Disease Primers, 2015Severe combined immunodeficiencies (SCIDs) comprise a group of rare, monogenic diseases that are characterized by an early onset and a profound block in the development of T lymphocytes. Given that adaptive immunity is abrogated, patients with SCID are prone to recurrent infections caused by both non-opportunistic and opportunistic pathogens, leading ...
Benedicte Neven+5 more
openaire +2 more sources
Gene therapy of severe combined immunodeficiencies
Immunological Reviews, 2000Primary immunodeficiency diseases (PID) are attractive candi dates for a gene therapy approach because many of these disorders convey a poor prognosis while a number of the genes mutated in these conditions have been identified. Gene transfer into hematopoietic stem cells (HSC) should, in theory, lead to a cure of the disease.
Salima Hacein-Bey+6 more
openaire +3 more sources
Jak3 and the pathogenesis of severe combined immunodeficiency
Molecular Immunology, 2004The discovery that Jak3 mutations are a significant cause of severe combined immunodeficiency (SCID), a rare inherited defect characterized by lymphopenia, has provided valuable insights into the functions of Jak3 in lymphoid development and function.
Paul S. Changelian+8 more
openaire +3 more sources
Treatment of severe combined immunodeficiency by transplantation
Blut, 1981This review is meant to show that all approaches other than the use of genotypically or phenotypically identical family donors for bone marrow transplantation aimed at the treatment of SCID leave a lot of unsolved questions open. The results are inconsistant but successful cases have been reported with the various methods.
openaire +3 more sources
Gene therapy of severe combined immunodeficiencies
Nature Reviews Immunology, 2002The concept that the outcome of a devastating disease can be modified by inserting a transgene into abnormal cells is appealing. However, the gene-transfer technologies that are available at present have limited the success of gene therapy so far. Nevertheless, severe combined immunodeficiencies are a useful model, because gene transfer can confer a ...
Marina Cavazzana-Calvo+2 more
openaire +3 more sources
Dyschromia Related to Severe Combined Immunodeficiency
The American Journal of Dermatopathology, 2013Severe combined immunodeficiency includes a group of diseases characterized by different inherited immunological defects. A 4-month-old girl diagnosed with Omenn syndrome, a subtype of severe combined immunodeficiency presenting with generalized erythroderma, was referred to our hospital for an allogeneic stem cell transplantation.
Paola Maldonado-Cid+6 more
openaire +3 more sources
Screening for severe combined immunodeficiency in newborns
Journal of Allergy and Clinical Immunology, 2012This issue of the Journal is devoted to the critical concept of screening for severe combined immunodeficiency (SCID), a long-sought goal of clinical immunologists engaged in hematopoietic stem cell transplantation (HSCT) for SCID, a congenital disease of many causes that is fatal in the first 1 to 2 years of life. The clinical immunologists chosen for
William T. Shearer, William T. Shearer
openaire +3 more sources